Axel Gaston Glasmacher
Presidente en 4D PHARMA PLC .
Cargos activos de Axel Gaston Glasmacher
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| 4D PHARMA PLC | Independent Dir/Board Member | 08/01/2019 | - |
| Presidente | 17/04/2020 | - | |
| Director/Miembro de la Junta | 08/01/2019 | 17/04/2020 | |
| RYVU THERAPEUTICS S.A. | Director/Miembro de la Junta | 01/10/2019 | - |
| ACTIVE BIOTECH AB | Director/Miembro de la Junta | 01/01/2020 | - |
| Independent Dir/Board Member | 01/01/2020 | - | |
| The Cancer Drug Development Forum | Director/Miembro de la Junta | - | - |
| Treasurer | - | - | |
| AG Life Science Consulting Gmbh & Co. Kg | Director Ejecutivo | - | - |
| Director/Miembro de la Junta | 01/03/2018 | - | |
| Glasmacher Verwaltungs GmbH | Director Ejecutivo | - | - |
| Director/Miembro de la Junta | - | - | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Miembro de la Junta | 01/07/2021 | - |
Historial de carrera de Axel Gaston Glasmacher
Antiguos cargos conocidos de Axel Gaston Glasmacher.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CELGENE | Director Técnico/Científico/I+D | 01/05/2006 | 01/02/2018 |
Formación de Axel Gaston Glasmacher.
| University of Bonn | Doctorate Degree |
Estadísticas
Internacional
| Alemania | 4 |
| Estados Unidos | 3 |
| Suecia | 2 |
Operativa
| Director/Board Member | 7 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Empresas privadas | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| The Cancer Drug Development Forum | |
| AG Life Science Consulting Gmbh & Co. Kg | |
| Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |
